-
Where Are We Now
18 Sep 2025 07:58 GMT
… briefly made me a millionaire. Human Genome Sciences, EntreMed, ViroPharma, Incyte, and Aware …
-
Maze Therapeutics Appoints Misbah Tahir as Chief Financial Officer
02 Sep 2025 11:00 GMT
… . (acquired by Amgen Inc.), and Human Genome Sciences Inc. (acquired by GSK plc …
-
Chronic Inflammatory Demyelinating Polyneuropathy Market Report 2025 | Grifols, Kedrion Biopharma, Octapharma, AstraZeneca's Alexion, Argenx, Horizon Therapeutics, and Biogen Lead Innovations - ResearchAndMarkets.com
20 Aug 2025 18:12 GMT
… Therapeutics plc)
Biogen Inc.
GlaxoSmithKline (Human Genome Sciences, Inc.)
Pfizer Inc.
Takeda Pharmaceutical …
-
Chronic Inflammatory Demyelinating Polyneuropathy Market Report 2025 Distribution Channel, Route Of Administration, And Region Analysis And Forecast To 2035
11 Aug 2025 11:44 GMT
… Therapeutics plc) Biogen Inc. GlaxoSmithKline (Human Genome Sciences, Inc.) Pfizer Inc. Takeda Pharmaceutical …
-
Human Genome Sciences Raises $100 Million from Private Offering
21 Sep 2019 11:05 GMT
… adjustment in certain circumstances.
Human Genome Sciences plans to use the … facility.
General corporate purposes.
Human Genome Sciences develops pharmaceutical products to … William A. Haseltine, CEO, Human Genome Sciences, 9410 Key West Ave., Rockville …
-
Veranova appoints Thomas Rohrer as vice president of bioconjugation
30 Jul 2025 11:21 GMT
… director of process development at Human Genome Sciences (later acquired by GSK), Otsuka …
-
Flashpoint Therapeutics Appoints Barry Labinger as CEO
29 Jul 2025 20:22 GMT
… his previous leadership positions at Human Genome Sciences, Bristol Myers Squibb, and Abbott …
-
Flashpoint Therapeutics Appoints Barry Labinger as Chief Executive Officer
28 Jul 2025 22:40 GMT
… leadership positions, including those at Human Genome Sciences, Bristol Myers Squibb, and Abbott … roles at Immunex, 3M Pharmaceuticals, Human Genome Sciences, Emergent BioSolutions, Bristol Myers Squibb …
-
Veranova Appoints Thomas Rohrer VP of Bioconjugation
28 Jul 2025 17:36 GMT
… Director of Process Development at Human Genome Sciences (later acquired by GSK), Otsuka …